Curtiss-Wright has dropped 20% in a month to $577.99, yet the short-selling apparatus around it remains almost entirely inert — that disconnect is the most interesting thing about the stock right now.
The price action has been punishing. The stock fell another 5.2% on the week and is now sitting roughly $210 below the Street's mean price target of $786. That gap reflects how sharply sentiment has deteriorated since the August earnings print, when CW dropped 7.6% the day after results — its steepest single-day post-earnings move in recent history. The five-day follow-through was nearly as bad, adding another leg lower. The next earnings event isn't until November 4, so there is no near-term catalyst to force a re-rating either way.
Short sellers, despite the selloff, have barely moved. Short interest is just 2% of the free float — a low absolute level — and while it has crept up roughly 6% on the week and 8.5% over the month, the absolute position remains small. Borrow costs underscore this: the cost to borrow has actually fallen sharply, down 35% on the week to just 0.28%, its lowest level in the 30-day window. Availability in the lending market is effectively unconstrained — the availability reading is at its ceiling, meaning the lending pool is almost entirely unused. There is no meaningful short squeeze pressure here, and no sign that professional shorts are piling in to drive the stock lower. The selloff is being driven by something other than short-side conviction.
Options tell a similar story of drift rather than alarm. The put/call ratio is running at 1.01, almost exactly in line with its 20-day average of 1.03 — a z-score of -0.15, which is as neutral as it gets. The PCR did spike into the 1.3-1.4 range during mid-to-late August as the stock was selling off hardest, suggesting some hedging demand at the lows. But it has since retreated to average, implying options traders are no longer actively reaching for downside protection at these levels.
The Street is cautious but not alarmed. Piper Sandler initiated coverage this week with a Neutral rating and a $665 target — notably below the consensus mean of $786 but well above the current price of $578. That initiation is worth flagging: it is the freshest piece of analyst opinion on the stock, and the below-consensus target suggests at least one new voice thinks the crowd is still too optimistic. The broader analyst community has been a consistent buyer of the bull case, with Stifel and Citi repeatedly lifting targets through the first half of the year. The consensus remains Hold. The EPS surprise factor score sits at the 75th percentile, reflecting the strong 14% beat in the August print, but forward EPS momentum scores are weak — ranking in the 22nd percentile for 12-month forward year-on-year growth. That is the tension: the company is executing well on the current book, but the Street is increasingly sceptical about what the next few years look like. The bear case centers on order delays — $50 million in Defense Electronics orders pushed out of Q3 2025 due to continuing resolution uncertainty — and the revenue-recognition risks that come with percentage-of-completion accounting on multi-year programs.
Peer context reinforces the sector-wide pressure. GE fell 5.3% on the week, AIR dropped 8%, and HWM slid 3.5%. BWXT was the outlier, gaining 7.9% — its nuclear exposure giving it a different driver from the broader defense electronics group. CW's 5.2% weekly decline puts it in the middle of the peer pack, neither the worst performer nor a clear relative winner.
Insider activity adds a subtle note of caution. The Chief Growth Officer sold $641,000 of stock on August 27, outside of any 10b5-1 plan — a discretionary sale at $619, well above where the stock closed the following week. Net insider activity across the 90-day window is negative at roughly -$701,000. The values are not large enough to be alarming, but the direction is consistent with management trimming into strength rather than buying the dip.
The November 4 earnings date is the next hard event on the calendar, and given back-to-back post-earnings declines of 5-8%, the market's tolerance for further guidance slippage on Defense Electronics orders will be the central question to watch.
See the live data behind this article on ORTEX.
Open CW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
